G4X-25698-29722
4 vaccinations
3 coded responses
45 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 983 / WA
- Registered
- 2021-08-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-03
Registered in v-safe
-
2021-08-03
Dose 1 — Pfizer-BioNTech
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-09
- 2021-08-10
- 2021-08-17
- 2021-08-24
-
2021-08-30
Dose 2 — Pfizer-BioNTech
-
2021-08-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-13
- 2021-09-20
-
2021-09-27
Survey response — day 28, dose 2MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-11
- 2021-11-29
-
2022-02-04
Dose 3 — Pfizer-BioNTech
-
2022-02-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-02-06
- 2022-02-07
- 2022-02-08
- 2022-02-09
- 2022-02-10
- 2022-02-11
- 2022-02-18
-
2022-02-27
Survey response — day 21, dose 3MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2022-03-04
- 2022-03-11
- 2022-03-18
-
2022-05-06
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-08-07
-
2022-10-23
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-02
Health check-in — day 7, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-11-06
- 2022-11-13
- 2022-11-20
- 2022-11-27
- 2022-12-06
- 2023-01-22
- 2023-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-03 | Pfizer-BioNTech | No |
| 2 | 2021-08-30 | Pfizer-BioNTech | No |
| 3 | 2022-02-04 | Pfizer-BioNTech | No |
| 4 | 2022-10-23 | Pfizer-BioNTech | Flu |
Free text
Release 9 — day 28, dose 2
Symptoms: Upper respiratory infection
Release 11 — day 21, dose 3
Symptoms: Cold
Release 11 — 3 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release